Recently, President Trump introduced Operation Warp Speed, promising a coronavirus vaccine by the end of the year. Even pro-vaccine advocates—especially pro-vaccine advocates—worry that we’re moving too fast.
A new study of #Hydroxychloroquine and #Chloroquine to treat #COVID19 was published this morning in The Lancet. The results? More deaths and arrhythmias in treated patients. [NOTE ADDENDUM: This study has been retracted. Here’s a link to my followup post.]
Didier Raoult is back, with a huge profile in the New York Times. Unfortunately, much is left out out of the profile of this “brave maverick,” even as evidence mounts against hydroxychloroquine and azithromycin for COVID-19.
On Wednesday, Dr. Anthony Fauci announced positive results for the antiviral drug remdesivir treating COVID-19. They were unimpressive and, suspiciously, announced by press release rather than scientific paper. It’s all very fishy, but one thing’s for sure. Gilead Sciences will make boatloads of money.
President Trump’s COVID-19 advisors include Dr. Oz, Rudy Giuliani, and Peter Navarro, the latter an economist who thinks he can science better than Anthony Fauci. Can science- and evidence-based medicine prevail with respect to hydroxychloroquine and coronavirus?